Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Psoriatic Arthritis Therapeutics Market: By Drug Class: TNF Inhibitors, Interleukin Inhibitors, PDE4 Inhibitors; By Route of Administration: Oral, Parenteral, Topical; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Psoriatic Arthritis Therapeutics Market Outlook
The global psoriatic arthritis therapeutics market is projected to grow at a CAGR of 6.5% in the forecast period of 2023-2028.
The market growth is being driven by the growing health awareness among the consumers. North America is leading the regional market in the industry as a result of the increasing demand for the product, especially, from the United States.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Segmentation
Psoriatic arthritis is a chronic disease associated with psoriasis. The condition needs timely treatment, the absence of which may lead to irreversible joint damage.
The psoriatic arthritis therapeutics market can be broadly categorised based on drug class, route of administration, and distribution channel.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on the drug class, the industry can be segmented into:
- TNF Inhibitors
- Interleukin Inhibitors
- PDE4 Inhibitors
- Others
Based on the route of administration, the industry can be divided into:
- Oral
- Parenteral
- Topical
Based on the distribution channel, the market can be divided into:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
The EMR report looks into the regional markets of psoriatic arthritis therapeutics like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The global psoriatic arthritis therapeutics market is being driven by the launch of new products, the increasing prevalence of psoriatic arthritis, and the growing consumer awareness regarding their health. Interleukin inhibitors are leading the drug class segment due to the rising emergence of biosimilars. North America, along with Europe, held more than half the overall market revenue in 2020 owing to rising commercial sales of products in the United States, the presence of key players, initiatives undertaken by the governments, the enactment of favourable policies, and the increasing incidence of psoriatic arthritis. The Asia Pacific is estimated to witness the fastest growth in the forecast period as a result of the increasing disposable income of consumers, improvement in healthcare facilities, economic growth, and the rising adoption of biosimilars in emerging markets such as China, India, and South Korea.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global psoriatic arthritis therapeutics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- AbbVie, Inc. (NYSE: ABBV)
- Janssen Global Services LLC (Johnson & Johnson)
- Novartis AG
- Amgen, Inc.
- Biogen Inc.
- Pfizer, Inc.
- Eli Lilly and Company
- UCB SA.
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Drug Class, Route of Administration, Distribution Channel, Region |
| Breakup by Drug Class | TNF Inhibitors, Interleukin Inhibitors, PDE4 Inhibitors, Others |
| Breakup by Route of Administration | Oral, Parenteral, Topical |
| Breakup by Distribution Channel | Hospital Pharmacies, Retail Pharmacies, Online Pharmacies |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | AbbVie, Inc. (NYSE: ABBV), Janssen Global Services LLC (Johnson & Johnson), Novartis AG (SWX: NOVN), Amgen, Inc. (NASDAQ: AMGN), Biogen Inc., Pfizer, Inc. (NYSE: PFE), Eli Lilly and Company (NYSE: LLY), UCB SA., Others. |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Psoriatic Arthritis Therapeutics Market Analysis
8.1 Key Industry Highlights
8.2 Global Psoriatic Arthritis Therapeutics Historical Market (2018-2022)
8.3 Global Psoriatic Arthritis Therapeutics Market Forecast (2023-2028)
8.4 Global Psoriatic Arthritis Therapeutics Market by Drug Class
8.4.1 TNF Inhibitors
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Interleukin Inhibitors
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 PDE4 Inhibitors
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.4.4 Others
8.5 Global Psoriatic Arthritis Therapeutics Market by Route of Administration
8.5.1 Oral
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Parenteral
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Topical
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.6 Global Psoriatic Arthritis Therapeutics Market by Distribution Channel
8.6.1 Hospital Pharmacies
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Retail Pharmacies
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Online Pharmacies
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.7 Global Psoriatic Arthritis Therapeutics Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 AbbVie Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Janssen Global Services, LLC (Johnson & Johnson)
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Novartis AG
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Amgen Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Biogen Inc.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Pfizer Inc.
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Eli Lilly and Company
12.2.7.1 Company Overview
12.2.7.2 Product Portfolio
12.2.7.3 Demographic Reach and Achievements
12.2.7.4 Certifications
12.2.8 UCB S.A.
12.2.8.1 Company Overview
12.2.8.2 Product Portfolio
12.2.8.3 Demographic Reach and Achievements
12.2.8.4 Certifications
12.2.9 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Psoriatic Arthritis Therapeutics Market: Key Industry Highlights, 2018 and 2028
2. Global Psoriatic Arthritis Therapeutics Historical Market: Breakup by Drug Class (USD Million), 2018-2022
3. Global Psoriatic Arthritis Therapeutics Market Forecast: Breakup by Drug Class (USD Million), 2023-2028
4. Global Psoriatic Arthritis Therapeutics Historical Market: Breakup by Route of Administration (USD Million), 2018-2022
5. Global Psoriatic Arthritis Therapeutics Market Forecast: Breakup by Route of Administration (USD Million), 2023-2028
6. Global Psoriatic Arthritis Therapeutics Historical Market: Breakup by Distribution Channel (USD Million), 2018-2022
7. Global Psoriatic Arthritis Therapeutics Market Forecast: Breakup by Distribution Channel (USD Million), 2023-2028
8. Global Psoriatic Arthritis Therapeutics Historical Market: Breakup by Region (USD Million), 2018-2022
9. Global Psoriatic Arthritis Therapeutics Market Forecast: Breakup by Region (USD Million), 2023-2028
10. North America Psoriatic Arthritis Therapeutics Historical Market: Breakup by Country (USD Million), 2018-2022
11. North America Psoriatic Arthritis Therapeutics Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Europe Psoriatic Arthritis Therapeutics Historical Market: Breakup by Country (USD Million), 2018-2022
13. Europe Psoriatic Arthritis Therapeutics Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Asia Pacific Psoriatic Arthritis Therapeutics Historical Market: Breakup by Country (USD Million), 2018-2022
15. Asia Pacific Psoriatic Arthritis Therapeutics Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Latin America Psoriatic Arthritis Therapeutics Historical Market: Breakup by Country (USD Million), 2018-2022
17. Latin America Psoriatic Arthritis Therapeutics Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Middle East and Africa Psoriatic Arthritis Therapeutics Historical Market: Breakup by Country (USD Million), 2018-2022
19. Middle East and Africa Psoriatic Arthritis Therapeutics Market Forecast: Breakup by Country (USD Million), 2023-2028
20. Global Psoriatic Arthritis Therapeutics Market Structure
Key Questions Answered in the Report
The global psoriatic arthritis therapeutics market is projected to grow at a CAGR of 6.5% between 2021 and 2026.
The major drivers of the industry include the increasing disposable income of consumers, improvement in healthcare facilities, economic growth, the rising adoption of biosimilars in emerging markets, the increasing prevalence of psoriatic arthritis, the growing consumer awareness regarding their health, and growing technological advancements.
The key market trend guiding the growth of the industry include the launch of new products.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest share in the market.
TNF inhibitors, interleukin inhibitors, and PDE4 inhibitors, among others are the major drug class of psoriatic arthritis therapeutics in the industry.
Oral, parenteral, and topical are the significant routes of administration of the product in the industry.
Hospital pharmacies, retail pharmacies, and online pharmacies are the significant distribution channels of psoriatic arthritis therapeutics.
The major players in the industry are AbbVie, Inc. (NYSE: ABBV), Janssen Global Services LLC (Johnson & Johnson), Novartis AG (SWX: NOVN), Amgen, Inc. (NASDAQ: AMGN), Biogen Inc., Pfizer, Inc. (NYSE: PFE), Eli Lilly and Company (NYSE: LLY), UCB SA., Others.
Analyst Review
The global psoriatic arthritis therapeutics market is driven by the improvement in healthcare facilities and the rising adoption of biosimilars in emerging markets. Aided by the technological advancements, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 6.5%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its drug class segments, the industry can be segmented into TNF inhibitors, interleukin inhibitors, and PDE4 inhibitors, among others. On the basis of route of administration, the industry is categorised into oral, parenteral, and topical. On the basis of distribution channels, the industry is divided into hospital pharmacies, retail pharmacies, and online pharmacies. The major regional markets for psoriatic arthritis therapeutics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the market. The key players in the above market include AbbVie, Inc. (NYSE: ABBV), Janssen Global Services LLC (Johnson & Johnson), Novartis AG (SWX: NOVN), Amgen, Inc. (NASDAQ: AMGN), Biogen Inc., Pfizer, Inc. (NYSE: PFE), Eli Lilly and Company (NYSE: LLY), UCB SA., Others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER